Akari Therapeutics

Developer of therapeutics for autoimmune and inflammatory diseases by targeting the complement system.

placeNew York City, New York, United States calendar_todayFounded 2005 groups5 employees language akaritx.com

Registered entities

Social engagement

Social engagement: 4.7K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

9 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital333%
Private equity333%
Bank & private debt111%
Other / undisclosed222%

Recent activity

29 Jun 2026
Milestone
regulatory
22 Jun 2026
Event
BIB International Convention
Coming soon